[Wild type p53 tumor suppressor gene and apoptosis in thyroid tumors: preliminary report].
作者信息
Kikuchi S, Hiraide H, Tamakuma S, Yamamoto M
机构信息
National Defense Medical College 1st Surgery, Tokorozawa, Japan.
出版信息
Nihon Geka Gakkai Zasshi. 1995 Aug;96(8):588.
PMID:7565583
Abstract
摘要
相似文献
1
[Wild type p53 tumor suppressor gene and apoptosis in thyroid tumors: preliminary report].[野生型p53肿瘤抑制基因与甲状腺肿瘤中的细胞凋亡：初步报告]
Nihon Geka Gakkai Zasshi. 1995 Aug;96(8):588.
2
Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.甲状腺良恶性病变中FHIT和p53基因的分子遗传学改变
Mutat Res. 2006 Jul 25;599(1-2):45-57. doi: 10.1016/j.mrfmmm.2006.01.021. Epub 2006 May 15.
3
Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.bcl-2、c-erbB-2、p53和p21（waf1-cip1）蛋白在甲状腺癌中的表达
J Exp Clin Cancer Res. 1999 Sep;18(3):363-7.
4
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.基因p53突变仅限于甲状腺低分化和未分化癌。
J Clin Invest. 1993 Apr;91(4):1753-60. doi: 10.1172/JCI116385.
5
Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.头颈部鳞状细胞癌中p53的突变与Bcl-2表达及顺铂诱导的细胞凋亡易感性增加相关。
Head Neck. 2004 Oct;26(10):870-7. doi: 10.1002/hed.20029.
6
7
8
Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.同时缺乏p53和Rb的小鼠主要发生内分泌起源的肿瘤。
Cancer Res. 1995 Mar 1;55(5):1146-51.
9
Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.突变型TP53对间变性甲状腺癌中逆转录病毒驱动的治疗性基因的调控
Cancer Gene Ther. 2005 Apr;12(4):381-8. doi: 10.1038/sj.cgt.7700789.
10
Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.表达野生型p53的金丝雀痘病毒用于对p53基因发生突变的鼠类肿瘤进行基因治疗。
Cancer Gene Ther. 2001 Feb;8(2):87-98. doi: 10.1038/sj.cgt.7700279.
Zotero 插件